{
    "nct_id": "NCT04054557",
    "official_title": "Utilization of Patient Reported Outcomes Generated by Electronic Medical Record and Smart Pill Bottles With Follow up Telehealth Encounters to Improve Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients",
    "inclusion_criteria": "* â€¢ Signed informed consent obtained prior to any study specific assessments and procedures\n\n  * Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n  * Women or men diagnosed with stage 0-III hormone receptor positive (estrogen receptor positive [ER] and /or progesterone receptor [PR] positive) breast cancer\n\n    * Staging for eligibility should utilize the most recent American Joint Committee on Cancer (AJCC) breast cancer staging version\n  * Patients (Pts) must have undergone breast surgery for their diagnosis of breast cancer\n  * Adjuvant endocrine therapy has been prescribed by their treating physician\n\n    * Patients may receive concurrent adjuvant radiation therapy plus endocrine therapy in the post-operative setting\n  * Have a cell phone with text messaging ability\n  * Have access to a computer, tablet, or smart phone to complete electronic surveys\n  * Patient must be willing to setup an online Jefferson MyChart account\n  * Patients who have been on endocrine therapy for more than 4 years\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pts with stage IV metastatic breast cancer\n* Patients unable to participate in patient portal communication (e.g. do not have either a smart phone, laptop, access to a computer and/ or access to a device with a webcam)\n* Pts who are non-English speaking and English illiterate",
    "miscellaneous_criteria": ""
}